U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Safe Use Initiative
  5. Safe Use Initiative - Extramural Research
  1. Safe Use Initiative

Safe Use Initiative - Extramural Research

FDA Broad Agency Announcement for the Advanced Research and Development of Regulatory Science

The U.S. Food and Drug Administration has an open, continuing announcement to solicit research and development in support of regulatory science and innovation. The Safe Use Initiative welcomes proposals to this announcement which support its mission and goal.

Safe Use funds subsection 8.5.1 of the BAA: Studies that develop innovative methods to create, facilitate and encourage research in the area of safe medication use that seeks to reduce preventable harm from drugs
  1. Nurse Pain Educator Pilot Program (NPE) – NEMA Research, Inc.
  2. FDA Health Care Professional Communication Project – Summer Productions  
  3. Integrated Clinical Decision Support System to Advance the Safe Use of Antibiotics – AZCERT, Inc.
  4. Pragmatic Risk Score for Severe Hypoglycemic Events – Kaiser Foundation Research Institute
  5. Optimizing the Use of Opioids Following Surgery – Kaiser Foundation Research Institute and Kaiser Permanente Northwest Center for Health Research
  6. Safe Stimulant Medication Prescribing for Adult ADHD – American Academy of Family Physicians (AAFP)
  7. Appearance and Performance Enhancing Substances Simulated Conversation for Health Professionals – The American Academy of Pediatrics (AAP)
  8. A Community Based Study of Adverse Effects of NSAIDS on the Kidney and Risk Mitigation to Reduce Preventable Harm – Albany College of Pharmacy and Health Sciences
  9. High-Alert Medication Safety Self-Assessment for Hospitals and Targeted Risk Reduction Tool Development – Institute for Safe Medication Practices (ISMP) 
  10. National Standardization of Intravenous (IV) and Oral Liquid Medications – American Society of Health-System Pharmacists (ASHP)
  11. Identifying Best Practices for the Safe Use of Pediatric Cough and Cold Medications – New York University
  12. Educational Resource for the Effective Communication Between Health Care Professionals and Patients About Impairing Risks of Prescribed Medication in Relation to Driving – Traffic Injury Research Foundation (TIRF)
  13. Real-time Risk Stratification for Hypo- or Hyperglycemia to Enhance Glucose Management Outcomes in Hospitals – University of Florida
  14. Comparative Effectiveness of Disease Education Messaging – WebMD
  15. FDA Physician Communication: Testing with Physician Portals – Summer Productions 
  16. Core Elements of Anticoagulation Stewardship Program – Anticoagulation Forum, Inc
  17. Evaluating the Impact of Flow Restrictors on Pediatric Exposures to Liquid Single-Ingredient Acetaminophen and Cough/Cold Products – Denver Health and Hospital Authority
  18. Manganese Contamination in Neonatal Parenteral Nutrition – Neonatal Research Institute
  19. A Scalable, Patient-Centered Approach for “Right-Sizing” Opioid Prescribing - University of Pennsylvania
  20. Analysis of Prescription Drug Monitoring Program (PDMP) Data Assessing the Impact of a State Intervention on High Risk Prescribers in New York State - Brandeis University
  21. Consumer and Physician Knowledge of Drug Quality - WebMD
  22. Perioperative Medication Safety Self-Assessment for Hospitals and Ambulatory Surgical Centers (ASCs) and Targeted Risk-Reduction Tool Development - Institute for Safe Medication Practices (ISMP)
  23. Suicide-Related Risks Associated with Prescription Opioid Deprescribing - Kaiser Foundation Hospitals

 

Related Information